Clinical Trials Browser

Phase 3 × Platinum Compounds × Gynecologic × Clear all

NCT04906993 2025-09-09

Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT02891824 2025-02-11

ATALANTE

Phase 3 Completed

Ovarian Neoplasms